Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von HC Wainwright 

Chimerix Inc. diskutieren

Chimerix Inc.

WKN: A1T65B / Symbol: CMRX / Name: Chimerix / Aktie / Biotechnologie & medizinische Forschung / Small Cap /

0,89 €
4,71 %

Einschätzung Buy
Rendite (%) -29,31 %
Kursziel 10,35
Veränderung
Endet am 03.03.24

Chimerix, Inc. (NASDAQ: CMRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $11.00 price target on the stock.
Ratings data for CMRX provided by MarketBeat

Chimerix, Inc. (NASDAQ: CMRX) is now covered by analysts at Robert W. Baird. They set an "outperform" rating on the stock.
Ratings data for CMRX provided by MarketBeat

Einschätzung Buy
Rendite (%) 0,86 %
Kursziel 10,09
Veränderung
Endet am 16.08.24

Chimerix, Inc. (NASDAQ: CMRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $11.00 price target on the stock.
Ratings data for CMRX provided by MarketBeat

Einschätzung Buy
Rendite (%) 1,30 %
Kursziel 5,51
Veränderung
Endet am 16.08.24

Chimerix, Inc. (NASDAQ: CMRX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $6.00 price target on the stock.
Ratings data for CMRX provided by MarketBeat

Chimerix, Inc. (NASDAQ: CMRX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for CMRX provided by MarketBeat